179 related articles for article (PubMed ID: 27563925)
21. An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors.
Dakappagari N; Neely L; Tangri S; Lundgren K; Hipolito L; Estrellado A; Burrows F; Zhang H
Biomarkers; 2010 Feb; 15(1):31-8. PubMed ID: 19747088
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.
Ambade A; Catalano D; Lim A; Mandrekar P
Hepatology; 2012 May; 55(5):1585-95. PubMed ID: 22105779
[TBL] [Abstract][Full Text] [Related]
23. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Barzegar A; Akbarzadeh A; Shahabi A; Barekati-Mowahed M; Zarghami N
Biomed Pharmacother; 2018 Jun; 102():608-617. PubMed ID: 29602128
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of heat shock protein 90 attenuates post‑angioplasty intimal hyperplasia.
Kassem MM; Muqri F; Dacosta M; Bruch D; Gahtan V; Maier KG
Mol Med Rep; 2020 Apr; 21(4):1959-1964. PubMed ID: 32319637
[TBL] [Abstract][Full Text] [Related]
25. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90 inhibitors: new mode of therapy to overcome endocrine resistance.
Wong C; Chen S
Cancer Res; 2009 Nov; 69(22):8670-7. PubMed ID: 19861537
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein 90 inhibition by 17-Dimethylaminoethylamino-17-demethoxygeldanamycin protects blood-brain barrier integrity in cerebral ischemic stroke.
Qi J; Liu Y; Yang P; Chen T; Liu XZ; Yin Y; Zhang J; Wang F
Am J Transl Res; 2015; 7(10):1826-37. PubMed ID: 26692927
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors.
Chai RC; Vieusseux JL; Lang BJ; Nguyen CH; Kouspou MM; Britt KL; Price JT
Mol Oncol; 2017 May; 11(5):567-583. PubMed ID: 28306192
[TBL] [Abstract][Full Text] [Related]
30. Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.
Reikvam H; Nepstad I; Sulen A; Gjertsen BT; Hatfield KJ; Bruserud Ø
Expert Opin Investig Drugs; 2013 May; 22(5):551-63. PubMed ID: 23586877
[TBL] [Abstract][Full Text] [Related]
31. The effect of inhibition of heat-shock proteins on thiram-induced tibial dyschondroplasia.
Genin O; Hasdai A; Shinder D; Pines M
Poult Sci; 2012 Jul; 91(7):1619-26. PubMed ID: 22700507
[TBL] [Abstract][Full Text] [Related]
32. Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin.
Bull EE; Dote H; Brady KJ; Burgan WE; Carter DJ; Cerra MA; Oswald KA; Hollingshead MG; Camphausen K; Tofilon PJ
Clin Cancer Res; 2004 Dec; 10(23):8077-84. PubMed ID: 15585643
[TBL] [Abstract][Full Text] [Related]
33. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts.
San Francisco IF; DeWolf WC; Peehl DM; Olumi AF
Int J Cancer; 2004 Nov; 112(2):213-8. PubMed ID: 15352032
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury.
Choudhury A; Bullock D; Lim A; Argemi J; Orning P; Lien E; Bataller R; Mandrekar P
Alcohol Clin Exp Res; 2020 Jun; 44(6):1300-1311. PubMed ID: 32282939
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses.
Tukaj S; Tiburzy B; Manz R; de Castro Marques A; Orosz A; Ludwig RJ; Zillikens D; Kasperkiewicz M
Exp Dermatol; 2014 Aug; 23(8):585-90. PubMed ID: 24961936
[TBL] [Abstract][Full Text] [Related]
36. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis.
Sanderson S; Valenti M; Gowan S; Patterson L; Ahmad Z; Workman P; Eccles SA
Mol Cancer Ther; 2006 Mar; 5(3):522-32. PubMed ID: 16546966
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
38. Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy.
Cui XB; Yu ZY; Wang W; Zheng YQ; Liu W; Li LX
Integr Cancer Ther; 2012 Mar; 11(1):61-7. PubMed ID: 21498475
[TBL] [Abstract][Full Text] [Related]
39. HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair.
Koll TT; Feis SS; Wright MH; Teniola MM; Richardson MM; Robles AI; Bradsher J; Capala J; Varticovski L
Mol Cancer Ther; 2008 Jul; 7(7):1985-92. PubMed ID: 18645008
[TBL] [Abstract][Full Text] [Related]
40. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
